Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin
Offer reference number: CM/PHS/23/5703
The period of the framework is 1 April 2025 to 31 December 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 15 months. The total maximum framework agreement duration, including extension options, will be no more than 48 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Bio Products Laboratory Ltd | 07343036 | £905,187,090 | LOBBYIST Garnish Hall Enterprises Ltd (1 quarter) |
| CSL Behring UK Ltd | 01622483 | £905,187,090 | LOBBYIST Burkitt Communications Ltd (1 quarter) |
| Grifols UK Ltd. | 01456099 | £905,187,090 | - |
| LFB | - | £905,187,090 | - |
| Octapharma Limited | 02372699 | £905,187,090 | - |
| Takeda UK Ltd | 03362860 | £905,187,090 | LOBBYIST Hill & Knowlton Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (2 quarters) Burkitt Communications Ltd (1 quarter) Incisive Health Ltd (1 quarter) FORMER MP Sir Kevin Barron— Employment and earnings (former) |
Government spending data: These suppliers have received £50,644,531 in 1,439 payments (over £25k) from Guy's and St Thomas' NHS FT, East Sussex Healthcare NHS Trust, Manchester University NHS Foundation Trust, Maidstone and Tunbridge Wells NHS Trust, Royal Cornwall Hospitals NHS Trust and 13 more public bodies (2018-04-04 to 2026-03-31).